72
Participants
Start Date
October 31, 2008
Primary Completion Date
July 31, 2010
Study Completion Date
November 30, 2010
Placebo
This is the identical buffer solution in which AERAS-402 is formulated. The placebo (1.0 mL volume) was administered by intramuscular (IM) injection to the deltoid area on Study Day 0 for groups 1 and 2 and Study Day 0 and 42 for group 3.
AERAS-402 3 x 10^8 vp
AERAS-402 was administered by single intramuscular (IM) injection to the deltoid area on Study Day 0
AERAS-402 3 x 10^9 vp
AERAS-402 was administered by single intramuscular (IM) injection to the deltoid area on Study Day 0
AERAS-402 3 x 10^10 vp
AERAS-402 was administered by intramuscular (IM) injection to the deltoid area on Study Days 0 and 42.
University of Cape Town Lung Institute Pty (Ltd), Cape Town
Lead Sponsor
Crucell Holland BV
INDUSTRY
Aeras
OTHER